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Abstract
Background: Infection of the lower airways by rhinovirus, a member of the picornavirus family,
is an important cause of wheezing illnesses in infants, and plays an important role in the
pathogenesis of rhinovirus-induced asthma exacerbations. Given the absence of natural rhinovirus
infections in rodents, we investigated whether an attenuated form of mengovirus, a picornavirus
whose wild-type form causes systemic rather than respiratory infections in its natural rodent hosts,
could induce airway infections in rats with inflammatory responses similar to those in human
rhinovirus infections.
Results: After inoculation with 107 plaque-forming units of attenuated mengovirus through an
inhalation route, infectious mengovirus was consistently recovered on days 1 and 3 postinoculation
from left lung homogenates (median Log10 plaque-forming units = 6.0 and 4.8, respectively) and
right lung bronchoalveolar lavage fluid (median Log10  plaque-forming units = 5.8 and 4.0,
respectively). Insufflation of attenuated mengovirus, but not vehicle or UV-inactivated virus, into
the lungs of BN rats caused significant increases (P < 0.05) in lower airway neutrophils and
lymphocytes in the bronchoalveolar lavage fluid and patchy peribronchiolar, perivascular, and
alveolar cellular infiltrates in lung tissue sections. In addition, infection with attenuated mengovirus
significantly increased (P < 0.05) lower airway levels of neutrophil chemoattractant CXCR2 ligands
[cytokine-induced neutrophil chemoattractant-1 (CINC-1; CXCL1) and macrophage inflammatory
protein-2 (MIP-2; CXCL2)] and monocyte chemoattractant protein-1 (MCP-1; CCL2) in
comparison to inoculation with vehicle or UV-inactivated virus.
Conclusion: Attenuated mengovirus caused a respiratory infection in rats with several days of
viral shedding accompanied by a lower airway inflammatory response consisting of neutrophils and
lymphocytes. These features suggest that mengovirus-induced airway infection in rodents could be
a useful model to define mechanisms of rhinovirus-induced airway inflammation in humans.
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Background
Human rhinovirus (HRV) infections are the most fre-
quent cause of common colds and virus-induced asthma
exacerbations, and wheezing HRV infections in infancy
are associated with an increased risk for the development
of childhood asthma [1-3]. A central conundrum with
regard to HRV, a member of the picornavirus family, is
explaining how a virus that usually causes a self-limiting
upper airway infection, a common cold, can induce
asthma exacerbations and provoke persistent lower air-
way sequelae in susceptible children [4,5]. An important
clue in addressing this issue is the substantial evidence
that HRV can infect the lower airways [6-11]. HRV infec-
tion of lower airway epithelial cells induces the secretion
of a variety of proinflammatory cytokines, chemokines,
and mediators [4].
Neutrophils are the predominant inflammatory cell ini-
tially recruited to the airways during HRV infections
[12,13], and clinical studies have demonstrated that there
is a positive correlation between this inflammatory
response and respiratory symptoms and airway dysfunc-
tion [14-17]. Although these relationships have been
observed in a variety of clinical and experimental infec-
tion studies, the nature of this relationship is still enig-
matic. It is possible that 1) neutrophilic inflammation
causes respiratory symptoms, 2) neutrophils recruited to
the airways in response to HRV infection have antiviral
effects and contribute to resolution of the infection, or 3)
neutrophilic inflammation is an epiphenomenon that
does not significantly affect the course of the disease.
Finally, perhaps the difference between a relatively une-
ventful cold and more severe HRV-induced airway seque-
lae resides in the balance between beneficial and
detrimental effects of the neutrophilic inflammatory
response.
Progress in understanding the relationship between HRV
infection, inflammation, and respiratory symptoms has
been significantly hampered by the absence of rodent-spe-
cific rhinoviruses. Recently, murine experimental models
have been established using either minor group HRV in
wild-type mice or major group HRV in mice that are trans-
genic for human intercellular adhesion molecule-1
(ICAM-1; CD54), the receptor for major group HRV
[18,19]. While these models will be useful, a significant
drawback to these models is that HRV replication is short-
lived (≤ 24 h) in the mouse. In studying the relationship
between viral replication, inflammation, and respiratory
dysfunction, it would be advantageous to develop a
model with viral replication lasting several days, as occurs
during clinical or experimental infections with HRV.
Mengovirus is a picornavirus that naturally infects rodents
[20], and the native virus causes systemic infections that
resemble poliovirus infections, rather than HRV infec-
tions, of humans. The poly(C) tract in the distal region of
the 5' untranslated region of the mengovirus genome is a
critical virulence determinant that inhibits interferon
responses [21-25]. A panel of attenuated mengovirus
mutants with varying deletions of the poly(C) tract (wild-
type mengovirus has a poly(C) tract length of 44) has
been derived, including vMC0, which has no poly(C) tract
[21-25]. In contrast to the systemic and often lethal infec-
tions caused by wild type mengovirus, intracerebral or
intraperitoneal administration of vMC0 induces self-lim-
ited infections, and vMC0 also stimulates vigorous type I
interferon responses [21-25]. Furthermore, attenuated
mengoviruses replicate well in epithelial cells but poorly
in macrophage lineage cells [25]. These features are simi-
lar to those of HRV infection [4], and led us to hypothe-
size that inoculation of rats with vMC0 via inhalation
could produce infection limited to the respiratory tract,
and could serve as a model for HRV infections in humans.
Results
Expression of infectious virus in the lungs after inhalation 
of attenuated mengovirus
To examine whether attenuated mengovirus could induce
lower airway infections in rats, 107 plaque-forming units
(PFU) of attenuated mengovirus, vMC0, an equivalent
amount of UV-inactivated vMC0, or vehicle were insuf-
flated into the lungs of adult BN rats. On days 1 and 3
postinoculation, significant levels of infectious mengovi-
rus were recovered from left lung homogenates (median
Log10 PFU = 6.0 and 4.8, respectively) and right lung bron-
choalveolar lavage (BAL) fluid (median Log10 PFU = 5.8
and 4.0, respectively) of BN rats inoculated with the atten-
uated mengovirus, vMC0 (Figure 1; P < 0.005). By day 5
postinoculation, viral titers in the lung homogenates and
BAL fluid of vMC0-inoculated rats were either low or
undetectable. Infectious mengovirus was not detected in
lung homogenates and BAL fluid from BN rats inoculated
with either UV-inactivated vMC0 or vehicle. Examination
of brain, heart, and spleen homogenates and plasma
revealed no evidence of systemic infection with vMC0.
Reduction in body weight gain after inhalation of 
attenuated mengovirus
A reduction in body weight or in the rate of body weight
gain is a sensitive measure of viral respiratory infections in
rodents [26]. The percent gain in body weight from the
day of the inoculation to day 3 postinoculation was signif-
icantly lower in BN rats inoculated with 107 PFU of vMC0
(median = 0.8%; n = 10 rats) than in those receiving the
vehicle (median = 2.2%; n = 6 rats; P = 0.04). However,
there was no significant difference between the percent
gain in body weight in rats inoculated with UV-inacti-
vated vMC0 (median = 1.6%; n = 5 rats) and those inocu-
lated with vehicle, indicating the requirement forVirology Journal 2009, 6:122 http://www.virologyj.com/content/6/1/122
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replication-competent virus for the observed effects on
body weight.
Development of neutrophilic lower airway inflammation 
after inhalation of attenuated mengovirus
Insufflation of vMC0 (107 PFU) into the lungs of adult BN
rats induced the recruitment of neutrophils and lym-
phocytes into the lower airways. The total number of BAL
cells and the numbers of BAL neutrophils and lym-
phocytes were significantly elevated on days 3 and 5 posti-
noculation in BN rats inoculated with attenuated
mengovirus compared with those inoculated with an
equivalent amount of UV-inactivated vMC0  or vehicle
(Figure 2; P < 0.05). Levels of BAL lymphocytes were also
significantly elevated on day 1 postinoculation in vMC0-
inoculated BN rats as compared with vehicle-inoculated
rats (Figure 2; P < 0.05). No significant differences were
observed among the vMC0-, UV-inactivated vMC0-, and
vehicle-inoculated groups with regard to the numbers of
BAL macrophages or eosinophils. Examination of
Giemsa-stained lung sections revealed patchy peribron-
chial, perivascular, and alveolar cellular infiltrates in the
lungs of BN rats inoculated with 107 PFU of vMC0 but not
in those inoculated with vehicle or UV-inactivated vMC0
(Figure 3). These data demonstrate the development of a
neutrophilic and lymphocytic lower airway inflammatory
response in rats after inhalation of attenuated mengovi-
rus, which required replication-competent virus.
Expression of CXCR2 ligands in the lower airways after 
inhalation of attenuated mengovirus
Given the significant neutrophilia in the lower airways
that was induced in BN rats by inhalation of vMC0, we
examined the BAL fluid for the expression of the rat
CXCR2 ligands, CINC-1 and MIP-2, which are neutrophil
chemoattractants [27]. The BAL fluid levels of CINC-1 and
MIP-2 were significantly elevated on days 1, 3, and 5
postinoculation in rats inoculated with 107 PFU of vMC0
as compared with those inoculated with vehicle or an
equivalent amount of UV-inactivated vMC0 (Figure 4A
and 4B; P ≤ 0.05).
Expression of MCP-1 in the lower airways after inhalation 
of attenuated mengovirus
Because HRV infection induces high levels of MCP-1
expression [28], and MCP-1 indirectly contributes to neu-
trophil recruitment to the lungs [29-32], we examined the
BAL fluid from BN rats that had been inoculated with 107
PFU of vMC0 for MCP-1 expression. The levels of MCP-1
in BAL fluid were significantly increased on days 1 and 3
or day 3 postinoculation in vMC0-inoculated rats com-
pared with vehicle- or UV-inactivated vMC0-inoculated
rats, respectively (Figure 4C; P < 0.05). As shown with
regard to CXCR2 ligand expression, UV-inactivation of
vMC0 abrogated its ability to induce a significant elevation
in BAL fluid MCP-1 levels, demonstrating the need for
replication-competent virus.
Effect of inoculation dose on inflammatory response to 
inhalation of attenuated mengovirus
Inoculation with a ten-fold lower dose of vMC0 yielded a
similar inflammatory response in the lower airways.
Insufflation of 106 PFU of vMC0 into the lungs of BN rats
(n = 4) induced a significant increase (P < 0.05) in the
numbers [106 cells: median (interquartile range)] of neu-
trophils [0.19 (0.16, 0.21)] and lymphocytes [0.23 (0.20,
0.30)], but not total cells, eosinophils, or macrophages in
the BAL fluid on day 3 postinoculation as compared with
the values from vehicle-inoculated rats. In addition, the
levels [pg: median (interquartile range)] of CINC-1 [715
(611, 835)], MIP-2 [188 (168, 208)], and MCP-1 [385
(266, 452)] in the BAL fluid were significantly elevated (P
< 0.05) in these rats as compared with vehicle-inoculated
controls. An inoculation dose of 105 PFU of vMC0 was
substantially less effective at generating an inflammatory
response in the lower airways of the rats, leading to the
recruitment of about 75% fewer BAL neutrophils and 60%
fewer BAL lymphocytes on day 3 postinoculation com-
Lung viral titers after inhalation of attenuated mengovirus Figure 1
Lung viral titers after inhalation of attenuated men-
govirus. Viral titers in left lung homogenates and BAL fluid 
(obtained from the right lung) from BN rats inoculated with 
107 PFU of attenuated mengovirus, vMC0, an equivalent 
amount of UV-inactivated vMC0, or vehicle were determined 
by plaque assays. Data are the total amount of virus present 
in the lung homogenate or BAL fluid (virus concentrations 
were multiplied by the volumes of lung homogenate or BAL 
fluid). Symbols represent data from individual rats. Dotted 
lines indicate the limits of detection. * P < 0.005 (vMC0 vs. 
vehicle and UV-inactivated vMC0).Virology Journal 2009, 6:122 http://www.virologyj.com/content/6/1/122
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Recruitment of neutrophils and lymphocytes to the lungs after inhalation of attenuated mengovirus Figure 2
Recruitment of neutrophils and lymphocytes to the lungs after inhalation of attenuated mengovirus. Numbers 
of (A) total cells, (B) neutrophils, (C) lymphocytes, (D) eosinophils, and (E) macrophages in the BAL fluid harvested on days 1, 
3, and 5 postinoculation from the right lungs of BN rats inoculated with 107 PFU of vMC0 (n = 4, 10, and 4 rats, respectively) 
and on day 3 postinoculation from those inoculated with an equivalent amount of UV-inactivated vMC0 (n = 5 rats) or vehicle 
(n = 7 rats). Data are presented as box plots. * P < 0.05 (mengovirus vs. vehicle); † P < 0.05 (vMC0 vs. UV-inactivated vMC0).Virology Journal 2009, 6:122 http://www.virologyj.com/content/6/1/122
Page 5 of 10
(page number not for citation purposes)
Recruitment of inflammatory cell infiltrates to the lungs after  inhalation of attenuated mengovirus Figure 3
Recruitment of inflammatory cell infiltrates to the 
lungs after inhalation of attenuated mengovirus. 
Giemsa-stained sections of the left lungs from BN rats inocu-
lated with (A) vehicle, (B) vMC0 (107 PFU) or (C) an equiva-
lent amount of UV-inactivated vMC0. Lungs were harvested 
on day 3 postinoculation. Magnification, 20×.
B
C
A
Figure 4Virology Journal 2009, 6:122 http://www.virologyj.com/content/6/1/122
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pared with that observed using inoculation doses of 107 or
106 PFU.
Effect of inhalation of attenuated mengovirus on 
pulmonary physiology and airway hyperresponsiveness 
(AHR)
To examine whether infection of the lower airways with
attenuated mengovirus induced changes in pulmonary
physiology, either vehicle or 107 PFU of vMC0 were insuf-
flated into the lungs of adult BN rats, and pulmonary
function was measured on day 3 postinoculation. No sig-
nificant differences were observed between vehicle- and
vMC0-inoculated groups of rats with regard to respiratory
system resistance (Rrs) or the input impedance variables,
Newtonian resistance (Rn), tissue viscance (G), and
elastance (H), either at baseline or in response to metha-
choline challenge (Figure 5 and data not shown), indicat-
ing a lack of viral effects on pulmonary physiology and
AHR.
Discussion
The establishment of useful small animal models to study
HRV pathogenesis has been an important goal to enable
mechanistic studies and facilitate the development of new
therapies. The earliest reported effort to develop a HRV
infection model in mice required very large input doses of
virus and pretreatment of the mice with actinomycin D
[33]. Recently, more robust murine experimental models
of HRV infection have been established. These models
employ either a murine cell culture-adapted minor group
HRV in wild-type mice or a major group HRV in mice that
are transgenic for human ICAM-1 [18,19]. Although the
development of these novel tools represents a significant
advance in the study of HRV-induced airway inflamma-
tion, an important limitation is that HRV shedding is lim-
ited to ≤ 24 h postinoculation [18].
In the rat model described here, infectious mengovirus
was consistently detected in the lungs at high levels, and
persisted for at least 3 days after inoculation. The inocula-
tion dose of 106–107 PFU of attenuated mengovirus in the
rats was similar to the dose of 5 × 106 TCID50 (50% tissue-
culture infective dose) administered in the HRV models in
mice [18,19], especially considering that the body weight
of the rats is about an order of magnitude greater com-
pared to that of mice. Furthermore, inhalation of attenu-
ated mengovirus, but not vehicle or UV-inactivated virus,
into the lungs of BN rats resulted in increases in chemok-
ines (CINC-1, MIP-2, and MCP-1) and cellular inflamma-
tion (neutrophils, lymphocytes, and total BAL cells).
Compared to the HRV mouse models, infection with
vMC0 represents a rodent model of picornavirus-induced
airway inflammation in which the roles of viral replica-
tion and persistence are more prominent.
Mengovirus-induced expression of CXCR2 ligands is con-
sistent with the increased expression of CXCR2 ligands
that is observed in response to rhinovirus infection [34-
36]. A similar induction of CXCR2 ligands was also
observed in the murine HRV infection models [18,19].
We also observed the induction of MCP-1 expression in
response to inhalation of attenuated mengovirus, which
represents another similarity between this rat model of
attenuated mengovirus-induced airway inflammation
Effect of inhalation of attenuated mengovirus on pulmonary  physiology Figure 5
Effect of inhalation of attenuated mengovirus on pul-
monary physiology. BN rats were inoculated with either 
vehicle or 107 PFU of vMC0 (n = 5 rats per group), and on 
day 3 postinoculation, pulmonary physiology measurements 
were obtained after exposure to aerosols of normal saline 
followed by escalating concentrations of methacholine. Val-
ues for respiratory system resistance (Rrs) are presented as 
the group means ± the standard error. There were no signif-
icant differences between the vehicle- and vMC0-inoculated 
groups.
Inhalation of attenuated mengovirus enhanced pulmonary  expression of the chemokines, CINC-1, MIP-2, and MCP-1 Figure 4
Inhalation of attenuated mengovirus enhanced pul-
monary expression of the chemokines, CINC-1, MIP-
2, and MCP-1. BAL fluid was harvested on days 1, 3, and 5 
postinoculation from the right lungs of BN rats inoculated 
with 107 PFU of vMC0 (n = 4, 10, and 4 rats, respectively) and 
on day 3 postinoculation from those inoculated with an 
equivalent amount of UV-inactivated vMC0 (n = 5 rats) or 
vehicle (n = 5–6 rats), and (A) CINC-1, (B) MIP-2, and (C) 
MCP-1 levels were determined by ELISA. Data are the total 
amount of chemokine recovered from the right lung BAL 
(ELISA values, corrected for the 15× concentration, were 
multiplied by the BAL fluid volume). (A, B) Data are pre-
sented as box plots. (C) Symbols represent data from individ-
ual rats; bars indicate medians. * P < 0.05, ‡ P = 0.05 (vMC0 
vs. vehicle); † P < 0.05 (vMC0 vs. UV-inactivated vMC0).Virology Journal 2009, 6:122 http://www.virologyj.com/content/6/1/122
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and human host responses to HRV infection [28]. There-
fore, the induction of rat CXC2 ligand and MCP-1 expres-
sion in airway fluids in response to inhalation of
attenuated mengovirus closely resembles the HRV-
induced enhancement of these chemokines.
Another similarity between this rat model and HRV infec-
tion in humans is the relative kinetics of the viral infection
vs. the lower airway neutrophilic inflammatory response.
Mengovirus titers in the lung peak earlier than the neu-
trophilic inflammatory response in the lower airways.
This parallels data from experimental HRV inoculations in
human volunteers [11,13]. In addition, the patchiness of
the mengovirus-induced airway inflammation in this rat
model is consistent with the patchy infection of airway
epithelial cells observed in HRV infections in human sub-
jects [11,37-39].
Infection of the lower airways with mengovirus did not
result in significant changes in baseline pulmonary phys-
iology measurements or in AHR to methacholine chal-
lenge in this rat model. It is important to note that
experimentally naïve adult rats without existing airway
disease were used in these studies. Similar to this rat
model, several studies involving experimental HRV inoc-
ulations of healthy, nonasthmatic, nonallergic human
subjects have demonstrated no changes in baseline pul-
monary function or AHR after HRV infection [10,40-44].
In one study showing a small change in AHR after experi-
mental HRV infection of nonasthmatic, nonallergic sub-
jects, the small difference was only detected by employing
a methacholine concentration that was a half-log higher
than the highest concentration typically used [45]. In con-
trast, experimental inoculation with HRV has been shown
to increase AHR in individuals with asthma and/or aller-
gic rhinitis in several studies [10,17,44,46,47], although
not in others [40,41,43,45,48]. Therefore, the absence of
changes in AHR in these healthy adult rats without exist-
ing airway disease is consistent with the outcomes of
experimental HRV infections in healthy humans who had
no underlying airway disease, such as asthma or allergic
rhinitis. The absence of viral effects on AHR in this men-
govirus model and in the experimental HRV inoculations
in humans is consistent with the murine experimental
model of HRV infection described by Bartlett et al. in
which there was no increase in AHR to methacholine chal-
lenge after HRV infection unless the BALB/c mice had also
been sensitized and challenged with allergen [18]. How-
ever, in the murine experimental HRV infection model
described by Newcomb et al., an increase in AHR to meth-
acholine challenge was observed after infection of C57BL/
6 mice with HRV [19], which may be related to the use of
a different mouse strain. Overall, the lack of significant
changes in pulmonary physiology during mengovirus-
induced respiratory infection in adult rats without existing
airway disease is consistent with previous observations in
experimental HRV infections in humans. In future studies,
it will be of interest to investigate the effects of mengovi-
rus-induced respiratory infection on rats with existing air-
way injury related to prior exposures to allergens or other
respiratory viruses [49] with the objective of modeling
aspects of HRV-induced asthma exacerbations.
A potential limitation of this animal model is the use of
mengovirus, which is neurotropic, to serve as a model for
HRV, which primarily causes respiratory infections. In this
regard, it is important to note that poliovirus, which is
closely related to HRV, is also neurotropic. The attenuated
mengovirus, vMC0, used in these studies induced a self-
limited respiratory infection when administered through
an inhalation route. This indicates that there is plasticity
in the tissue tropism of vMC0 that makes it suitable for a
model of picornavirus-induced airway infection and
inflammation. Another consideration is that there are
both similarities and differences in CXCR2 and its ligands
between rats and humans [50]. Humans express IL-8 and
two IL-8 receptors, CXCR1 and CXCR2, whereas rats do
not express an IL-8 ortholog and only express CXCR2.
However, rats do express relevant CXCR2 ligands, such as
CINC-1 and MIP-2, which are functional analogs of IL-8
with regard to neutrophil recruitment and activation. We
believe that the rat represents an attractive, relevant, and
simplified model for examining the role of CXC chemok-
ines in neutrophil recruitment and activation in response
to picornavirus-induced respiratory infection because of
the reduced number of chemokines and chemokine
receptors to be examined.
Conclusion
Overall, our data support the feasibility of using this novel
rat model of picornavirus-induced lower airway infection
and inflammation to study, among other questions, the
role of neutrophilic inflammation in the host response to
picornavirus-induced respiratory infections. Although
this model does not fully encompass all aspects of HRV
infection in humans, it does demonstrate a remarkable
number of parallel developments that will provide novel
opportunities to study the interactions between picornavi-
ral replication and the host antiviral immune responses in
a relevant small animal model.
Methods
Animals
BN/SsN male rats were purchased from Harlan (Indiana-
polis, IN) and had a median body weight of 250 g when
used for inoculation studies. The rats were housed in
HEPA-filtered isolation cubicles (Britz and Co., Wheat-
land, WY) in an American Association for Accreditation of
Laboratory Animal Care-accredited laboratory animal
facility at the University of Wisconsin School of MedicineVirology Journal 2009, 6:122 http://www.virologyj.com/content/6/1/122
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and Public Health. All procedures were approved by the
University of Wisconsin Animal Care and Use Committee
and conformed to the Guide for the Care and Use of Lab-
oratory Animals (1996).
Virus
Stock preparations of the attenuated mengovirus, vMC0
(which has no poly(C) tract) [21-25], were prepared by
transfection of HeLa cells with viral RNA transcribed from
a plasmid encoding the vMC0 genome followed by ampli-
fication of viral titers via passage in HeLa cell cultures as
described [51]. Supernates from uninfected HeLa cell cul-
tures were used as vehicle controls, and UV-inactivated
vMC0 stocks were prepared by exposing vMC0 to a germi-
cidal UV lamp at a distance of 10 cm for 1 h. Plaque assays
using HeLa cells were employed to determine the titer of
the active virus preparations and to verify UV-inactivation.
Active virus was undetectable (< 10 PFU/ml) in the UV-
inactivated preparations.
Virus inoculation
Rats were lightly anesthetized by inhalation of 5% isoflu-
rane, and vMC0, UV-inactivated vMC0, or vehicle in a total
volume of 0.1 ml were insufflated into the lungs via an
orotracheal catheter.
Measurements of pulmonary inflammation
At various times after inoculation, rats were anesthetized
with urethane and euthanized by exsanguination. The
chest was opened, and the left mainstem bronchus was
clamped to allow BAL of the right lung. The right lung was
filled with phosphate buffered saline (PBS) to total lung
capacity by gravity and drained 5 times, the BAL fluid was
centrifuged, and the cell pellet was resuspended in 1 ml
PBS. The total number of BAL leukocytes was determined
with an automated cell counter (model Z1, Beckman
Coulter, Hialeah, FL), and cytospin slides were prepared
for a differential leukocyte count based on 200 cells. BAL
fluid was concentrated 15× using a centrifugal filter device
with a molecular weight cutoff of 5,000 (Millipore, Bed-
ford, MA) and stored at -80°C until analyzed for chemok-
ine expression. Samples of unconcentrated BAL fluid were
used for viral titer determinations. The left lung was either
removed for viral titer determinations or filled to total
lung capacity by gravity with 10% buffered formalin for
histological analysis.
Measurements of pulmonary physiology
Rats were anesthetized with pentobarbital (Abbott, North
Chicago, IL), intubated via tracheostomy, paralyzed with
succinylcholine HCl (Sigma, St. Louis, MO), and venti-
lated mechanically (flexiVent, SCIREQ, Montreal, Can-
ada). Aerosol challenges were delivered by the ventilator
via an inline nebulizer (Aeroneb, SCIREQ) as 10 breaths
of aerosolized normal saline, followed by methacholine
HCl (Sigma) solutions in concentrations of 0.1, 0.3, 1, 3,
and 10 mg/ml. Each challenge was preceded by two lung
inflations to 30 cmH2O, and the challenges were deliv-
ered every 4 min. After each aerosol challenge, measure-
ments of pulmonary physiology were performed by the
flexiVent system every 15 s for 2 min, alternating measures
of Rrs with measures of input impedance variables (Rn, G,
and H). For each variable, the highest value occurring after
each aerosol challenge was recorded as the response, ref-
erenced to the value obtained after saline challenge.
Measurement of viral titers
Viral titers in left lung homogenates, prepared in PBS
(10% w/v) and clarified by centrifugation, and in uncon-
centrated BAL fluid were determined by plaque assay
using HeLa cells as described [24,51]. Briefly, HeLa cell
monolayers were inoculated with dilutions of the sam-
ples, incubated for 24–48 h at 37°C (until plaques form),
formalin fixed, stained with crystal violet, and scored for
plaques. Stock vMC0 preparations served as the positive
control.
Histological assessment of pulmonary inflammation
Sections (5 μM) were prepared from formalin-fixed, par-
affin-embedded left lungs. Giemsa staining was per-
formed on these sections, which were evaluated for
inflammation by light microscopy.
Measurement of chemokine expression
Chemokine levels in BAL fluid were determined using
commercially available rat-specific enzyme-linked immu-
nosorbent assay (ELISA) kits for CINC-1 (R&D Systems,
Minneapolis, MN), MIP-2, and MCP-1 (Biosource,
Camarillo, CA) with sensitivities of 7.8, 7.8, and 8 pg/ml,
respectively, according to the manufacturers' instructions.
Statistical analysis
Analysis of variance (general linear model) was per-
formed on the BAL fluid CINC-1 and MIP-2 ELISA data
and on pulmonary physiology data after a log transforma-
tion, and Fischer's least significant difference test was used
for planned pairwise comparisons. A residual analysis was
employed to test the adequacy of the models. Nonpara-
metric tests were used to analyze all other data. For com-
parisons between two groups, the Mann-Whitney test was
used. The Kruskal-Wallis test was used for comparisons
among three or more groups and was followed by
planned pairwise comparisons using the Mann-Whitney
test. Because infectious virus was undetectable in the lung
homogenate and BAL fluid samples from rats inoculated
with vehicle or UV-inactivated virus, these groups were
combined for statistical analysis of viral titers. Box plots
depict the median and the interquartile range between the
25th and 75th percentile, and whiskers show the 10th and
90th percentiles. Analyses were performed using the sta-Virology Journal 2009, 6:122 http://www.virologyj.com/content/6/1/122
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tistical software package SYSTAT 11.0 (Systat Software,
Chicago, IL).
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